Alpine Immune Sciences Inc reports results for the quarter ended in June - Earnings Summary

Alpine Immune Sciences

10/08/2021 23:11

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 46 cents​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of 40 cents per share.
* Revenue rose 942.5% to $7.19 million from a year ago; 
analysts expected $6.48 million. 
* Alpine Immune Sciences Inc's reported EPS for the quarter was
a loss of 46 cents​.
* The mean earnings estimate of analysts had fallen by
about 13.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Alpine Immune Sciences Inc shares had fallen by 0.6% this
quarter and lost 29.0% so far this year.
* The company reported a quarterly loss of $11.03 million.
* Wall Street's median 12-month price target for Alpine Immune
Sciences Inc is $21.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 10:11 p.m.  ​All
figures in US dollars unless otherwise stated